Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.

Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group.

J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298.

PMID:
18986246
[PubMed - indexed for MEDLINE]
Free Article
2.

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.

Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, EholiƩ S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group.

Lancet. 2006 Jun 17;367(9527):1981-9.

PMID:
16782488
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk